%PDF-1.5
%
46 0 obj
<>
endobj
48 0 obj
<>stream
2017-03-01T08:45:12-05:00
QuarkXPress(R) 9.3
2024-03-28T04:43:42-07:00
2024-03-28T04:43:42-07:00
QuarkXPress(R) 9.3
application/pdf
Utility of Dose Frequency Adjustment in Tocilizumab Administration for Rheumatoid Arthritis
%%DocumentProcessColors: Black
%%EndComments
uuid:facd189d-1dd1-11b2-0a00-8e09271d5700
uuid:facd18a1-1dd1-11b2-0a00-bf0000000000
endstream
endobj
12 0 obj
<>]>>
endobj
40 0 obj
<>
endobj
41 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
42 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
43 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
44 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
45 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
70 0 obj
[75 0 R]
endobj
71 0 obj
<>stream
HWKsW% K$W@%ETR!y7=В7-H3ߣW~_}A\
{nY8OE,]dtwSpDKjO6H胧dY?n覿#wm6]dHD@g@
1阺Xao:LseqCΖJe:W,^l7a[QGQ`mAmNpQkr-oTe¨I2Ec^VPvr?C@mQ٬e+-xYv
R#z@8붧jߓ/d&%CDBkЭ&=:̴ntK